Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities DOI Creative Commons
Huan Wang, Shiqi Lin, Xiying Wu

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(20)

Published: May 7, 2023

Abstract Liposomes have received tremendous attention as a class of versatile pharmaceutical vehicles great potential over the past several decades. However, application liposomes encounters major challenges due to knowledge gaps in their vivo delivery process. Immunoglobulin M (IgM) displays both pervasiveness and complexity regulating biological functions well eliciting adverse effects liposomes. Understanding, mitigating, exploiting duality IgM are prerequisites for achieving various biomedical applications In this review, intricate relationship between environments has been summarized, with an emphasis on regulatory performance Corresponding solutions also discussed evade IgM‐mediated opsonization safe efficient drug delivery.

Language: Английский

Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome DOI Creative Commons
Makhloufi Zoulikha, Qingqing Xiao,

George Frimpong Boafo

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2021, Volume and Issue: 12(2), P. 600 - 620

Published: Aug. 12, 2021

The use of small interfering RNAs (siRNAs) has been under investigation for the treatment several unmet medical needs, including acute lung injury/acute respiratory distress syndrome (ALI/ARDS) wherein siRNA may be implemented to modify expression pro-inflammatory cytokines and chemokines at mRNA level. properties such as clear anatomy, accessibility, relatively low enzyme activity make a good target local therapy. However, translation is restricted by inefficient delivery therapeutics cells due naked siRNA. Thus, this review will focus on various systems that can used different barriers need surmounted development stable inhalable formulations human before ALI/ARDS become available in clinic.

Language: Английский

Citations

183

Approved Nanomedicine against Diseases DOI Creative Commons

Yuanchao Jia,

Yuxin Jiang,

Yonglong He

et al.

Pharmaceutics, Journal Year: 2023, Volume and Issue: 15(3), P. 774 - 774

Published: Feb. 26, 2023

Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases. Nanotechnology represents one the most effective approaches in elevating drug‘s treatment efficacy reducing toxicity by improving drug solubility, altering biodistribution, controlling release. The development materials has brought profound revolution medicine, significantly affecting various major diseases such as cancer, injection, cardiovascular experienced explosive growth past few years. Although clinical transition nanomedicine not very satisfactory, traditional drugs still occupy dominant position formulation development, but increasingly active have adopted nanoscale forms limit side effects improve efficacy. review summarized approved nanomedicine, its indications, properties commonly used nanocarriers nanotechnology.

Language: Английский

Citations

62

Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines DOI Creative Commons
Ujwal Havelikar,

Kabirdas B. Ghorpade,

Amit Kumar

et al.

Discover Nano, Journal Year: 2024, Volume and Issue: 19(1)

Published: Oct. 4, 2024

Nanomedicine has the potential to transform healthcare by offering targeted therapies, precise diagnostics, and enhanced drug delivery systems. The National Institutes of Health coined term "nanomedicine" describe use nanotechnology in biological system monitoring, control, diagnosis, treatment. continues receive increasing interest for rationalized therapeutics pharmaceutical agents achieve required response while reducing its side effects. However, as advance, concerns about toxicological effects have also grown. This review explores current state nanomedicine, focusing on types nanoparticles used their associated properties that contribute nanotoxicity. It examines mechanisms through which exert toxicity, encompassing various cellular molecular interactions. Furthermore, it discusses assessment methods employed evaluate nanotoxicity, in-vitro in-vivo models, well emerging techniques. addresses regulatory issues surrounding nanotoxicology, highlighting challenges developing standardized guidelines ensuring secure translation nanomedicine into clinical settings. ethical with understanding safety profile is essential effective therapeutic applications.

Language: Английский

Citations

17

Lipid carriers for mRNA delivery DOI Creative Commons
Wanting Zhang,

Yuxin Jiang,

Yonglong He

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2022, Volume and Issue: 13(10), P. 4105 - 4126

Published: Nov. 30, 2022

Messenger RNA (mRNA) is the template for protein biosynthesis and emerging as an essential active molecule to combat various diseases, including viral infection cancer. Especially, mRNA-based vaccines, a new type of vaccine, have played leading role in fighting against current global pandemic COVID-19. However, inherent drawbacks, large size, negative charge, instability, hinder its use therapeutic agent. Lipid carriers are distinguishable promising vehicles mRNA delivery, owning capacity encapsulate deliver negatively charged drugs targeted tissues release cargoes at desired time. Here, we first summarized structure properties different lipid carriers, such liposomes, liposome-like nanoparticles, solid lipid-polymer hybrid nanoemulsions, exosomes lipoprotein particles, their applications delivering mRNA. Then, development lipid-based formulations vaccine delivery systems was discussed highlighted. Recent advancements COVID-19 were emphasized. Finally, described our future vision perspectives this field.

Language: Английский

Citations

67

Responsive Hydrogels Based on Triggered Click Reactions for Liver Cancer DOI

Jiaqi Zhu,

Han Wu,

Zhen‐Li Li

et al.

Advanced Materials, Journal Year: 2022, Volume and Issue: 34(38)

Published: May 18, 2022

Abstract Globally, liver cancer, which is one of the major cancers worldwide, has attracted growing attention technological researchers for its high mortality and limited treatment options. Hydrogels are soft 3D network materials containing a large number hydrophilic monomers. By adding moieties such as nitrobenzyl groups to structure cross‐linked nanocomposite hydrogel, click reaction improves drug‐release efficiency in vivo, survival rate prolongs time cancer patients. The application hydrogel drug delivery system can not only enrich concentration at tumor site long but also effectively prevents distant metastasis residual cells. At present, researches have been working toward construction responsive systems, there few comprehensive articles systematically summarize these discoveries. Here, this systematic review summarizes synthesis methods related applications hydrogels with actions external or internal physiological stimuli. With different physical chemical stimuli, structural unit rearrangement controlled release drugs be used states.

Language: Английский

Citations

53

New antifungal strategies: Drug combination and co-delivery DOI
Ping Zhu, Yan Li, Ting Guo

et al.

Advanced Drug Delivery Reviews, Journal Year: 2023, Volume and Issue: 198, P. 114874 - 114874

Published: May 19, 2023

Language: Английский

Citations

29

Gout therapeutics and drug delivery DOI

Xiuju Peng,

Xiaotong Li, Bing Xie

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 362, P. 728 - 754

Published: Sept. 21, 2023

Language: Английский

Citations

28

Drug Delivery of Gelatin Nanoparticles as a Biodegradable Polymer for the Treatment of Infectious Diseases: Perspectives and Challenges DOI Open Access
Osama A. Madkhali

Polymers, Journal Year: 2023, Volume and Issue: 15(21), P. 4327 - 4327

Published: Nov. 5, 2023

In recent years, there has been a growing interest in the use of gelatin nanoparticles (GNPs) for treatment infectious diseases. The inherent properties these make them attractive options drug delivery. Their biocompatibility ensures that they can interact with biological systems without causing adverse reactions, while their biodegradability break down harmlessly body once function is performed. Furthermore, capacity controlled release therapeutic agents be delivered over sustained period, thereby enhancing efficacy. This review examines current landscape GNP-based delivery, specific focus on its potential applications and challenges context Key include controlling rates, ensuring nanoparticle stability under physiological conditions, scaling up production maintaining quality, mitigating immunogenic optimizing loading efficiency, tracking biodistribution clearance GNPs body. Despite hurdles, hold promising realm disease treatment. Ongoing research innovation are essential to overcome obstacles completely harness clinical applications.

Language: Английский

Citations

27

Confronting antifungal resistance, tolerance, and persistence: Advances in drug target discovery and delivery systems DOI
Lei Chen, Lanyue Zhang,

Yuyan Xie

et al.

Advanced Drug Delivery Reviews, Journal Year: 2023, Volume and Issue: 200, P. 115007 - 115007

Published: July 16, 2023

Language: Английский

Citations

26

Solubilization techniques used for poorly water-soluble drugs DOI Creative Commons

Bing Xie,

Yaping Liu, Xiaotong Li

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2024, Volume and Issue: 14(11), P. 4683 - 4716

Published: Sept. 2, 2024

About 40% of approved drugs and nearly 90% drug candidates are poorly water-soluble drugs. Low solubility reduces the drugability. Effectively improving bioavailability is a critical issue that needs to be urgently addressed in development application. This review briefly introduces conventional solubilization techniques such as solubilizers, hydrotropes, cosolvents, prodrugs, salt modification, micronization, cyclodextrin inclusion, solid dispersions, details crystallization strategies, ionic liquids, polymer-based, lipid-based, inorganic-based carriers bioavailability. Some most commonly used carrier materials for presented. Several using summarized. Furthermore, this summarizes mechanism each technique, reviews latest research advances challenges, evaluates potential clinical translation. could guide selection approach, dosage form, administration route Moreover, we discuss several promising attracting increasing attention worldwide.

Language: Английский

Citations

14